scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1025589332 |
P356 | DOI | 10.1186/S13014-016-0654-2 |
P932 | PMC publication ID | 4891890 |
P698 | PubMed publication ID | 27255678 |
P50 | author | Peter Hohenberger | Q114061176 |
P2093 | author name string | Ulrich Ronellenfitsch | |
Frederik Wenz | |||
Anna Simeonova | |||
Bernd Kasper | |||
Geraldine Rauch | |||
Jens Jakob | |||
P2860 | cites work | Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy | Q29547379 |
Outcome prediction in primary resected retroperitoneal soft tissue sarcoma: histology-specific overall survival and disease-free survival nomograms built on major sarcoma center data sets | Q30607290 | ||
Can dosimetric parameters predict acute hematologic toxicity in rectal cancer patients treated with intensity-modulated pelvic radiotherapy? | Q33424898 | ||
Complete pathologic response to neoadjuvant radiotherapy is predictive of oncological outcome in patients with soft tissue sarcoma. | Q34129461 | ||
Phase I trial of neoadjuvant conformal radiotherapy plus sorafenib for patients with locally advanced soft tissue sarcoma of the extremity | Q34129496 | ||
Phase II study of neoadjuvant bevacizumab and radiotherapy for resectable soft tissue sarcomas | Q34491021 | ||
Soft tissue sarcoma, version 2.2014. | Q34661218 | ||
A phase Ib/II translational study of sunitinib with neoadjuvant radiotherapy in soft-tissue sarcoma | Q34687036 | ||
Retroperitoneal sarcomas: patterns of care at diagnosis, prognostic factors and focus on main histological subtypes: a multicenter analysis of the French Sarcoma Group | Q35611869 | ||
Phase I trial of concurrent sunitinib and radiation therapy as preoperative treatment for soft tissue sarcoma | Q37190323 | ||
Efficacy of sunitinib and radiotherapy in genetically engineered mouse model of soft-tissue sarcoma | Q37322196 | ||
Prospective study of functional bone marrow-sparing intensity modulated radiation therapy with concurrent chemotherapy for pelvic malignancies | Q38017760 | ||
Hepatotoxicity of tyrosine kinase inhibitors: clinical and regulatory perspectives | Q38101884 | ||
The receptor tyrosine kinase inhibitor SU11248 impedes endothelial cell migration, tubule formation, and blood vessel formation in vivo, but has little effect on existing tumor vessels | Q45194202 | ||
Incidence of soft tissue sarcoma and beyond: a population-based prospective study in 3 European regions. | Q47880296 | ||
Evaluation of response after neoadjuvant treatment in soft tissue sarcomas; the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG) recommendations for pathological examination and reporting. | Q53233475 | ||
Combined radiation therapy and sunitinib for preoperative treatment of soft tissue sarcoma. | Q53464347 | ||
Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up | Q57570904 | ||
Local recurrence of localized soft tissue sarcoma | Q58876640 | ||
Long-Term Results of Two Prospective Trials of Preoperative External Beam Radiotherapy for Localized Intermediate- or High-Grade Retroperitoneal Soft Tissue Sarcoma | Q58876714 | ||
A phase I study on the combination of neoadjuvant radiotherapy plus pazopanib in patients with locally advanced soft tissue sarcoma of the extremities | Q87204655 | ||
P921 | main subject | phase I clinical trial | Q5452194 |
P304 | page(s) | 77 | |
P577 | publication date | 2016-06-03 | |
P1433 | published in | Radiation Oncology | Q2313370 |
P1476 | title | Combined sunitinib and radiation therapy for preoperative treatment of soft tissue sarcoma: results of a phase I trial of the German interdisciplinary sarcoma group (GISG-03). | |
P478 | volume | 11 |
Q90428468 | Role of stereotactic body radiation therapy for the management of renal cell carcinoma: tailoring treatment in the era of the "embarrassment of riches" |
Q64245963 | Safely combining trabectedin with radiotherapy to treat myxoid liposarcoma |
Q33705268 | The clinical application of angiostatic therapy in combination with radiotherapy: past, present, future |
Q64245975 | Trabectedin and RAdiotherapy in Soft Tissue Sarcoma (TRASTS): Results of a Phase I Study in Myxoid Liposarcoma from Spanish (GEIS), Italian (ISG), French (FSG) Sarcoma Groups |
Search more.